LEI: 549300Q7EXQQH6KF7Z84
25 April 2024
RTW Biotech Opportunities Ltd
Annual Financial Report
Year ended 31 December 2023
A tagged copy of the above document was submitted to the National Storage Mechanism on 25 April 2024 and is available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For Further Information:
| RTW Investments, LP | +44 (0)20 7959 6361 |
| Woody Stileman, Managing Director Krisha McCune, Director, Investor Relations |
|
|
|
|
About RTW Biotech Opportunities Ltd:
RTW Biotech Opportunities Ltd (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the website at www.rtwfunds.com/rtw-biotech-opportunities-ltd for more information.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
